PROPULSID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propulsid, and what generic alternatives are available?
Propulsid is a drug marketed by Janssen Pharms and Janssen Pharma and is included in three NDAs.
The generic ingredient in PROPULSID is cisapride monohydrate. There are two drug master file entries for this compound. Additional details are available on the cisapride monohydrate profile page.
Summary for PROPULSID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,543 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PROPULSID at DailyMed |
Recent Clinical Trials for PROPULSID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Temple University | N/A |
| American College of Gastroenterology | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for PROPULSID
US Patents and Regulatory Information for PROPULSID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | PROPULSID | cisapride monohydrate | SUSPENSION;ORAL | 020398-001 | Sep 15, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Janssen Pharma | PROPULSID QUICKSOLV | cisapride monohydrate | TABLET, ORALLY DISINTEGRATING;ORAL | 020767-001 | Nov 7, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-001 | Jul 29, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-002 | Dec 23, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROPULSID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-002 | Dec 23, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
| Janssen Pharms | PROPULSID | cisapride monohydrate | SUSPENSION;ORAL | 020398-001 | Sep 15, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
| Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-001 | Jul 29, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROPULSID
See the table below for patents covering PROPULSID around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Germany | 3267923 | ⤷ Try a Trial | |
| Slovakia | 682182 | N-(4-PIPERIDINYL)BENZAMIDE DERIVATIVES AND MANUFACTURING PROCESS THEREOF | ⤷ Try a Trial |
| Luxembourg | 88217 | ⤷ Try a Trial | |
| South Africa | 8207194 | ⤷ Try a Trial | |
| Ireland | 822378 | ⤷ Try a Trial | |
| Slovakia | 278380 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PROPULSID
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0076530 | SPC/GB93/037 | United Kingdom | ⤷ Try a Trial | |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
